id CRUZ_aeeeced653148861a45043fd2727d4b8
oai_identifier_str oai:www.arca.fiocruz.br:icict/57049
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Elias, Maria CarolinaSlavov, Svetoslav NanevLima, Alex Ranieri JeronimoMartins, Antonio JorgeBarros, Claudia Renata Dos SantosMoretti, Debora BotequioAraujo, Eduardo L.Marqueze, Elaine CristinaRibeiro, GabrielaRibeiro, Gabriela Mauric FrossardBernardino, Jardelina Souza TodaoKoser, Jaqueline ReginatoClemente, Luan GasparCrispin, Luiz Aurelio CamposAlcantara, Luiz Carlos JuniorCoutinho, Luiz LehmannGiovanetti, MartaSilva, Quetura OliveiraMachado Neto, RaulHaddad, RicardoKashima, SimoneViala, Vincent LouisCovas, Dimas TadeuSampaio, Sandra Coccuzzo2023-02-13T18:11:02Z2023-02-13T18:11:02Z2023ELIAS, Maria Carolina et al. A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations. BMC Public Health, v. 23, p. 1-9, 2023.1471-2458https://www.arca.fiocruz.br/handle/icict/5704910.1186/s12889-022-14867-2engBioMed CentralA traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populationsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleInstituto Butantan. São Paulo, SP, Brazil / Instituto Butantan. Center of Toxins, Immune Response and Cell Signaling. São Paulo, SP, Brazil.University of São Paulo. Ribeirão Preto Medical School. Blood Center of Ribeirão Preto. Ribeirão Preto, SP, Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.Loccus. São Paulo, SP, Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.Universidade de São Paulo. Centro de Genomica Funcional. Piracicaba, São Paulo, Brasil.Instituto Butantan. São Paulo, SP Brazil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.Universidade de São Paulo. Centro de Genomica Funcional. Piracicaba, São Paulo, Brasil.Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan. São Paulo, SP Brazil.University of São Paulo. Ribeirão Preto Medical School. Blood Center of Ribeirão Preto. Ribeirão Preto, SP, Brazil.Instituto Butantan. São Paulo, SP Brazil.University of São Paulo. Ribeirão Preto Medical School. Blood Center of Ribeirão Preto. Ribeirão Preto, SP, Brazil / Instituto Butantan. São Paulo, SP Brazil.Instituto Butantan, São Paulo, Brazil.Background: Brazil has been dramatically hit by the SARS-CoV-2 pandemic and is a world leader in COVID-19 morbidity and mortality. Additionally, the largest country of Latin America has been a continuous source of SARS-CoV-2 variants and shows extraordinary variability of the pandemic strains probably related to the country´s outstanding position as a Latin American economical and transportation hub. Not all regions of the country show sufficient infrastructure for SARS-CoV-2 diagnosis and genotyping which can negatively impact the pandemic response. Methods: Due to this reason and to disburden the diagnostic system of the inner São Paulo State, the Butantan Institute established the Mobile Laboratory (in Portuguese: LabMovel) for SARS-CoV-2 testing which started a trip of the most important "hotspots" of the most populous Brazilian region. The LabMovel initiated in two important cities of the State: Aparecida do Norte (an important religious center) and the Baixada Santista region which incorporates the port of Santos, the busiest in Latin America. The LabMovel was fully equipped with an automatized system for SARS-CoV-2 diagnosis and sequencing/genotyping. It also integrated the laboratory systems for patient records and results divulgation including in the Federal Brazilian Healthcare System. Results: Currently,16,678 samples were tested, among them 1,217 from Aparecida and 4,564 from Baixada Santista. We tracked the delta introductio in the tested regions with its high diversification. The established mobile SARS-CoV-2 laboratory had a major impact on the Public Health System of the included cities including timely delivery of the results to the healthcare agents and the Federal Healthcare system, evaluation of the vaccination status of the positive individuals in the background of exponential vaccination process in Brazil and scientific and technological divulgation of the fieldwork to the most vulnerable populations. Conclusions: The SARS-CoV-2 pandemic has demonstrated worldwide the importance of science to fight against this viral agent and the LabMovel shows that it is possible to integrate researchers, clinicians, healthcare workers and patients to take rapid actions that can in fact mitigate this and other epidemiological situations.BrazilCOVID-19LabMovelMolecular surveillanceReal-time detectionSARS-CoV-2info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/57049/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALA traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations.pdfA traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations.pdfapplication/pdf1623565https://www.arca.fiocruz.br/bitstream/icict/57049/2/A%20traveling%20SARS-CoV-2%20laboratory%20as%20part%20of%20a%20pandemic%20response%20among%20vulnerable%20Brazilian%20populations.pdf9d3c18048b304cdbf18554da1631e81cMD52icict/570492023-05-26 23:28:52.612oai:www.arca.fiocruz.br:icict/57049Q0VTU8ODTyBOw4NPIEVYQ0xVU0lWQSBERSBESVJFSVRPUyBBVVRPUkFJUwoKQW8gYWNlaXRhciBvcyBURVJNT1MgZSBDT05EScOHw5VFUyBkZXN0YSBDRVNTw4NPLCBvIEFVVE9SIGUvb3UgVElUVUxBUiBkZSBkaXJlaXRvcwphdXRvcmFpcyBzb2JyZSBhIE9CUkEgZGUgcXVlIHRyYXRhIGVzdGUgZG9jdW1lbnRvOgoKKDEpIENFREUgZSBUUkFOU0ZFUkUsIHRvdGFsIGUgZ3JhdHVpdGFtZW50ZSwgw6AgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaLCBlbQpjYXLDoXRlciBwZXJtYW5lbnRlLCBpcnJldm9nw6F2ZWwgZSBOw4NPIEVYQ0xVU0lWTywgdG9kb3Mgb3MgZGlyZWl0b3MgcGF0cmltb25pYWlzIE7Dg08KQ09NRVJDSUFJUyBkZSB1dGlsaXphw6fDo28gZGEgT0JSQSBhcnTDrXN0aWNhIGUvb3UgY2llbnTDrWZpY2EgaW5kaWNhZGEgYWNpbWEsIGluY2x1c2l2ZSBvcyBkaXJlaXRvcwpkZSB2b3ogZSBpbWFnZW0gdmluY3VsYWRvcyDDoCBPQlJBLCBkdXJhbnRlIHRvZG8gbyBwcmF6byBkZSBkdXJhw6fDo28gZG9zIGRpcmVpdG9zIGF1dG9yYWlzLCBlbQpxdWFscXVlciBpZGlvbWEgZSBlbSB0b2RvcyBvcyBwYcOtc2VzOwoKKDIpIEFDRUlUQSBxdWUgYSBjZXNzw6NvIHRvdGFsIG7Do28gZXhjbHVzaXZhLCBwZXJtYW5lbnRlIGUgaXJyZXZvZ8OhdmVsIGRvcyBkaXJlaXRvcyBhdXRvcmFpcwpwYXRyaW1vbmlhaXMgbsOjbyBjb21lcmNpYWlzIGRlIHV0aWxpemHDp8OjbyBkZSBxdWUgdHJhdGEgZXN0ZSBkb2N1bWVudG8gaW5jbHVpLCBleGVtcGxpZmljYXRpdmFtZW50ZSwKb3MgZGlyZWl0b3MgZGUgZGlzcG9uaWJpbGl6YcOnw6NvIGUgY29tdW5pY2HDp8OjbyBww7pibGljYSBkYSBPQlJBLCBlbSBxdWFscXVlciBtZWlvIG91IHZlw61jdWxvLAppbmNsdXNpdmUgZW0gUmVwb3NpdMOzcmlvcyBEaWdpdGFpcywgYmVtIGNvbW8gb3MgZGlyZWl0b3MgZGUgcmVwcm9kdcOnw6NvLCBleGliacOnw6NvLCBleGVjdcOnw6NvLApkZWNsYW1hw6fDo28sIHJlY2l0YcOnw6NvLCBleHBvc2nDp8OjbywgYXJxdWl2YW1lbnRvLCBpbmNsdXPDo28gZW0gYmFuY28gZGUgZGFkb3MsIHByZXNlcnZhw6fDo28sIGRpZnVzw6NvLApkaXN0cmlidWnDp8OjbywgZGl2dWxnYcOnw6NvLCBlbXByw6lzdGltbywgdHJhZHXDp8OjbywgZHVibGFnZW0sIGxlZ2VuZGFnZW0sIGluY2x1c8OjbyBlbSBub3ZhcyBvYnJhcyBvdQpjb2xldMOibmVhcywgcmV1dGlsaXphw6fDo28sIGVkacOnw6NvLCBwcm9kdcOnw6NvIGRlIG1hdGVyaWFsIGRpZMOhdGljbyBlIGN1cnNvcyBvdSBxdWFscXVlciBmb3JtYSBkZQp1dGlsaXphw6fDo28gbsOjbyBjb21lcmNpYWw7CgooMykgUkVDT05IRUNFIHF1ZSBhIGNlc3PDo28gYXF1aSBlc3BlY2lmaWNhZGEgY29uY2VkZSDDoCBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPCkNSVVogbyBkaXJlaXRvIGRlIGF1dG9yaXphciBxdWFscXVlciBwZXNzb2Eg4oCTIGbDrXNpY2Egb3UganVyw61kaWNhLCBww7pibGljYSBvdSBwcml2YWRhLCBuYWNpb25hbCBvdQplc3RyYW5nZWlyYSDigJMgYSBhY2Vzc2FyIGUgdXRpbGl6YXIgYW1wbGFtZW50ZSBhIE9CUkEsIHNlbSBleGNsdXNpdmlkYWRlLCBwYXJhIHF1YWlzcXVlcgpmaW5hbGlkYWRlcyBuw6NvIGNvbWVyY2lhaXM7CgooNCkgREVDTEFSQSBxdWUgYSBvYnJhIMOpIGNyaWHDp8OjbyBvcmlnaW5hbCBlIHF1ZSDDqSBvIHRpdHVsYXIgZG9zIGRpcmVpdG9zIGFxdWkgY2VkaWRvcyBlIGF1dG9yaXphZG9zLApyZXNwb25zYWJpbGl6YW5kby1zZSBpbnRlZ3JhbG1lbnRlIHBlbG8gY29udGXDumRvIGUgb3V0cm9zIGVsZW1lbnRvcyBxdWUgZmF6ZW0gcGFydGUgZGEgT0JSQSwKaW5jbHVzaXZlIG9zIGRpcmVpdG9zIGRlIHZveiBlIGltYWdlbSB2aW5jdWxhZG9zIMOgIE9CUkEsIG9icmlnYW5kby1zZSBhIGluZGVuaXphciB0ZXJjZWlyb3MgcG9yCmRhbm9zLCBiZW0gY29tbyBpbmRlbml6YXIgZSByZXNzYXJjaXIgYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVogZGUKZXZlbnR1YWlzIGRlc3Blc2FzIHF1ZSB2aWVyZW0gYSBzdXBvcnRhciwgZW0gcmF6w6NvIGRlIHF1YWxxdWVyIG9mZW5zYSBhIGRpcmVpdG9zIGF1dG9yYWlzIG91CmRpcmVpdG9zIGRlIHZveiBvdSBpbWFnZW0sIHByaW5jaXBhbG1lbnRlIG5vIHF1ZSBkaXogcmVzcGVpdG8gYSBwbMOhZ2lvIGUgdmlvbGHDp8O1ZXMgZGUgZGlyZWl0b3M7CgooNSkgQUZJUk1BIHF1ZSBjb25oZWNlIGEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTwpPU1dBTERPIENSVVogZSBhcyBkaXJldHJpemVzIHBhcmEgbyBmdW5jaW9uYW1lbnRvIGRvIHJlcG9zaXTDs3JpbyBpbnN0aXR1Y2lvbmFsIEFSQ0EuCgpBIFBvbMOtdGljYSBJbnN0aXR1Y2lvbmFsIGRlIEFjZXNzbyBBYmVydG8gZGEgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaIHJlc2VydmEKZXhjbHVzaXZhbWVudGUgYW8gQVVUT1Igb3MgZGlyZWl0b3MgbW9yYWlzIGUgb3MgdXNvcyBjb21lcmNpYWlzIHNvYnJlIGFzIG9icmFzIGRlIHN1YSBhdXRvcmlhCmUvb3UgdGl0dWxhcmlkYWRlLCBzZW5kbyBvcyB0ZXJjZWlyb3MgdXN1w6FyaW9zIHJlc3BvbnPDoXZlaXMgcGVsYSBhdHJpYnVpw6fDo28gZGUgYXV0b3JpYSBlIG1hbnV0ZW7Dp8OjbwpkYSBpbnRlZ3JpZGFkZSBkYSBPQlJBIGVtIHF1YWxxdWVyIHV0aWxpemHDp8Ojby4KCkEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVoKcmVzcGVpdGEgb3MgY29udHJhdG9zIGUgYWNvcmRvcyBwcmVleGlzdGVudGVzIGRvcyBBdXRvcmVzIGNvbSB0ZXJjZWlyb3MsIGNhYmVuZG8gYW9zIEF1dG9yZXMKaW5mb3JtYXIgw6AgSW5zdGl0dWnDp8OjbyBhcyBjb25kacOnw7VlcyBlIG91dHJhcyByZXN0cmnDp8O1ZXMgaW1wb3N0YXMgcG9yIGVzdGVzIGluc3RydW1lbnRvcy4KRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-05-27T02:28:52Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations
title A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations
spellingShingle A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations
Elias, Maria Carolina
Brazil
COVID-19
LabMovel
Molecular surveillance
Real-time detection
SARS-CoV-2
title_short A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations
title_full A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations
title_fullStr A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations
title_full_unstemmed A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations
title_sort A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations
author Elias, Maria Carolina
author_facet Elias, Maria Carolina
Slavov, Svetoslav Nanev
Lima, Alex Ranieri Jeronimo
Martins, Antonio Jorge
Barros, Claudia Renata Dos Santos
Moretti, Debora Botequio
Araujo, Eduardo L.
Marqueze, Elaine Cristina
Ribeiro, Gabriela
Ribeiro, Gabriela Mauric Frossard
Bernardino, Jardelina Souza Todao
Koser, Jaqueline Reginato
Clemente, Luan Gaspar
Crispin, Luiz Aurelio Campos
Alcantara, Luiz Carlos Junior
Coutinho, Luiz Lehmann
Giovanetti, Marta
Silva, Quetura Oliveira
Machado Neto, Raul
Haddad, Ricardo
Kashima, Simone
Viala, Vincent Louis
Covas, Dimas Tadeu
Sampaio, Sandra Coccuzzo
author_role author
author2 Slavov, Svetoslav Nanev
Lima, Alex Ranieri Jeronimo
Martins, Antonio Jorge
Barros, Claudia Renata Dos Santos
Moretti, Debora Botequio
Araujo, Eduardo L.
Marqueze, Elaine Cristina
Ribeiro, Gabriela
Ribeiro, Gabriela Mauric Frossard
Bernardino, Jardelina Souza Todao
Koser, Jaqueline Reginato
Clemente, Luan Gaspar
Crispin, Luiz Aurelio Campos
Alcantara, Luiz Carlos Junior
Coutinho, Luiz Lehmann
Giovanetti, Marta
Silva, Quetura Oliveira
Machado Neto, Raul
Haddad, Ricardo
Kashima, Simone
Viala, Vincent Louis
Covas, Dimas Tadeu
Sampaio, Sandra Coccuzzo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Elias, Maria Carolina
Slavov, Svetoslav Nanev
Lima, Alex Ranieri Jeronimo
Martins, Antonio Jorge
Barros, Claudia Renata Dos Santos
Moretti, Debora Botequio
Araujo, Eduardo L.
Marqueze, Elaine Cristina
Ribeiro, Gabriela
Ribeiro, Gabriela Mauric Frossard
Bernardino, Jardelina Souza Todao
Koser, Jaqueline Reginato
Clemente, Luan Gaspar
Crispin, Luiz Aurelio Campos
Alcantara, Luiz Carlos Junior
Coutinho, Luiz Lehmann
Giovanetti, Marta
Silva, Quetura Oliveira
Machado Neto, Raul
Haddad, Ricardo
Kashima, Simone
Viala, Vincent Louis
Covas, Dimas Tadeu
Sampaio, Sandra Coccuzzo
dc.subject.en.en_US.fl_str_mv Brazil
COVID-19
LabMovel
Molecular surveillance
Real-time detection
SARS-CoV-2
topic Brazil
COVID-19
LabMovel
Molecular surveillance
Real-time detection
SARS-CoV-2
description Instituto Butantan. São Paulo, SP, Brazil / Instituto Butantan. Center of Toxins, Immune Response and Cell Signaling. São Paulo, SP, Brazil.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-02-13T18:11:02Z
dc.date.available.fl_str_mv 2023-02-13T18:11:02Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv ELIAS, Maria Carolina et al. A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations. BMC Public Health, v. 23, p. 1-9, 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/57049
dc.identifier.issn.en_US.fl_str_mv 1471-2458
dc.identifier.doi.none.fl_str_mv 10.1186/s12889-022-14867-2
identifier_str_mv ELIAS, Maria Carolina et al. A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations. BMC Public Health, v. 23, p. 1-9, 2023.
1471-2458
10.1186/s12889-022-14867-2
url https://www.arca.fiocruz.br/handle/icict/57049
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/57049/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/57049/2/A%20traveling%20SARS-CoV-2%20laboratory%20as%20part%20of%20a%20pandemic%20response%20among%20vulnerable%20Brazilian%20populations.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
9d3c18048b304cdbf18554da1631e81c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008944796270592